COMPANY MILESTONE

  

Research & Development 

* Carried out R&D at the University of Perugia 


*Advanced to mammal group studies  

* All animal studies have proven success Regulatory + Clinical 


*Primate studies have been completed at various universities and clinics

* Successfully executed Human Safety; study approved by the Italian agency equivalent to FDA 
Credentials 

*Established, strong relationship with the US FDA;

ready to submit pre-IND for entry into phase 1 clinical trial 


*Built strong IP portfolio (granted global patents) 


*Presently in collaboration with Wake Forest Institute for Regenerative Medicine 


>150 Peer-reviewed articles under Dr. Riccardo Calafiore